Search Results - "Sveide, I."

AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks.

Authors: Mortato, Edoardo Talamonti, Marina Savastano, Lorenzo et al.

Source: Dermatology & Therapy. Apr2026, Vol. 16 Issue 4, p2191-2204. 14p.

Persistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patients-A retrospective register-based cohort study in Finland and Sweden.

Authors: Tskhvarashvili G Aher K Sveide I et al.

Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2025 Mar; Vol. 39 Suppl 1, pp. 50-64. Date of Electronic Publication: 2024 Aug 02.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Real-world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis.

Authors: Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.

Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2025 Mar; Vol. 39 Suppl 1, pp. 3-5. Date of Electronic Publication: 2025 Feb 24.

Publication Type: Editorial

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE; In Process